Wolfes Julian, Eckardt Lars
Klinik für Kardiologie II - Rhythmologie, Universitätsklinikum Münster, Albert-Schweitzer Campus 1, 48149, Münster, Deutschland.
Herzschrittmacherther Elektrophysiol. 2024 Dec;35(4):318-323. doi: 10.1007/s00399-024-01053-7. Epub 2024 Nov 13.
The new 2024 ESC guidelines on the management of patients with atrial fibrillation (AF) introduces the AF-CARE pathway as the central acronym for AF management. As a result, the management of Comorbidities and risk factors is moving to the forefront of AF management. However, the new guideline also includes important changes in Avoidance stroke and thromboembolism, such as a modified risk score (CHADS-VA) and a statement on anticoagulation in subclinical atrial fibrillation. There are also changes in the concepts of Rhythm and rate control with an upgrading of rhythm control and catheter ablation. Finally, the guideline recommends regular Evaluation and reassessment of the patient's course for optimal AF management. Here, we summarize key points of the new guidelines and discusses some recommendations on aspects that can also be assessed differently.
2024年欧洲心脏病学会(ESC)关于心房颤动(AF)患者管理的新指南引入了AF-CARE路径,作为AF管理的核心首字母缩写词。因此,合并症和危险因素的管理正走向AF管理的前沿。然而,新指南在预防中风和血栓栓塞方面也有重要变化,例如修改后的风险评分(CHADS-VA)以及关于亚临床心房颤动抗凝治疗的声明。在节律和心率控制概念方面也有变化,节律控制和导管消融得到了升级。最后,该指南建议对患者病程进行定期评估和重新评估,以实现最佳的AF管理。在此,我们总结新指南的要点,并讨论在某些方面也可进行不同评估的一些建议。